ELUTIA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.8 USD | -2.81% |
|
+16.21% | +75.93% |
| 06-21 | Lake Street Adjusts Elutia Price Target to $10 From $5, Maintains Buy Rating | MT |
| 06-20 | Cantor Fitzgerald Adjusts Price Target on Elutia to $11 From $5, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 105M | - | - | - | |||
| 94.22B | ||||||
| 37.76B | ||||||
| 32.5B | ||||||
| 27.75B | ||||||
| 16.13B |
- Stock Market
- Equities
- ELUT Stock
- Charts Elutia Inc.
- Sector Chart
